Aspire BioPharma, Inc. (ASBP)vsPDD Holdings Inc. (PDD)
ASBP
Aspire BioPharma, Inc.
$8.88
+5.21%
CONSUMER CYCLICAL · Cap: $11.80M
PDD
PDD Holdings Inc.
$77.47
-1.19%
CONSUMER CYCLICAL · Cap: $111.59B
Smart Verdict
WallStSmart Research — data-driven comparison
PDD Holdings Inc. generates 461576505% more annual revenue ($450.78B vs $97,660). PDD leads profitability with a 20.4% profit margin vs 0.0%. PDD earns a higher WallStSmart Score of 75/100 (B).
ASBP
Avoid22
out of 100
Grade: F
PDD
Strong Buy75
out of 100
Grade: B
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for ASBP.
Margin of Safety
+69.0%
Fair Value
$345.11
Current Price
$77.47
$267.64 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Attractively priced relative to earnings
Conservative balance sheet, low leverage
Generating 25.7B in free cash flow
Safe zone — low bankruptcy risk
Large-cap with strong market position
Every $100 of equity generates 21 in profit
Areas to Watch
0.0% revenue growth
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
Weak financial health signals
Earnings declined 11.2%
Comparative Analysis Report
WallStSmart ResearchBull Case : ASBP
The strongest argument for ASBP centers on Price/Book.
Bull Case : PDD
The strongest argument for PDD centers on P/E Ratio, Debt/Equity, Free Cash Flow. Profitability is solid with margins at 20.4% and operating margin at 24.7%. PEG of 0.68 suggests the stock is reasonably priced for its growth.
Bear Case : ASBP
The primary concerns for ASBP are Revenue Growth, EPS Growth, Market Cap.
Bear Case : PDD
The primary concerns for PDD are Piotroski F-Score, EPS Growth.
Key Dynamics to Monitor
ASBP profiles as a value stock while PDD is a mature play — different risk/reward profiles.
ASBP carries more volatility with a beta of 0.17 — expect wider price swings.
PDD is growing revenue faster at 8.1% — sustainability is the question.
PDD generates stronger free cash flow (25.7B), providing more financial flexibility.
Bottom Line
PDD scores higher overall (75/100 vs 22/100), backed by strong 20.4% margins. Both earn "Strong Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Aspire BioPharma, Inc.
CONSUMER CYCLICAL · AUTO PARTS · USA
Aspire Biopharma Holdings, Inc., early-stage biopharmaceutical company, engages in developing and marketing of disruptive technology for delivery mechanisms for do no harm drugs in the United States. The company is headquartered in Humacao, Puerto Rico.
Visit Website →PDD Holdings Inc.
CONSUMER CYCLICAL · INTERNET RETAIL · China
Pinduoduo Inc., operates an electronic commerce platform in the People's Republic of China. The company is headquartered in Shanghai, the People's Republic of China.
Visit Website →Compare with Other AUTO PARTS Stocks
Want to dig deeper into these stocks?